Randomized phase II study of palifermin for reducing dysphagia in patients receiving concurrent chemoradiotherapy for locally advanced unresectable non-small cell lung cancer
about
Clinical applications of palifermin: amelioration of oral mucositis and other potential indicationsRadioprotective agents for radiation therapy: future trends.Emerging targets for radioprotection and radiosensitization in radiotherapy.Emerging new clinical applications for palifermin: beyond its use in oral mucositis and graft versus host disease.Berberine hydrochloride inhibits cell proliferation and promotes apoptosis of non-small cell lung cancer via the suppression of the MMP2 and Bcl-2/Bax signaling pathways.
P2860
Randomized phase II study of palifermin for reducing dysphagia in patients receiving concurrent chemoradiotherapy for locally advanced unresectable non-small cell lung cancer
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Randomized phase II study of p ...... ble non-small cell lung cancer
@ast
Randomized phase II study of p ...... ble non-small cell lung cancer
@en
Randomized phase II study of p ...... ble non-small cell lung cancer
@nl
type
label
Randomized phase II study of p ...... ble non-small cell lung cancer
@ast
Randomized phase II study of p ...... ble non-small cell lung cancer
@en
Randomized phase II study of p ...... ble non-small cell lung cancer
@nl
prefLabel
Randomized phase II study of p ...... ble non-small cell lung cancer
@ast
Randomized phase II study of p ...... ble non-small cell lung cancer
@en
Randomized phase II study of p ...... ble non-small cell lung cancer
@nl
P2093
P2860
P1476
Randomized phase II study of p ...... ble non-small cell lung cancer
@en
P2093
Bartomeu Massuti
Dietmar P Berger
Gregory A Otterson
Maciej J Krzakowski
Richard Lizambri
Wolfgang Schuette
Yuhchyau Chen
P2860
P304
P356
10.1097/JTO.0B013E31822F6526
P577
2012-01-01T00:00:00Z